Journal article

Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.

  • Ahmadpanah M Behavioral Disorders and Substances Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Sheikhbabaei M Behavioral Disorders and Substances Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Haghighi M Behavioral Disorders and Substances Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Roham F Behavioral Disorders and Substances Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Jahangard L Behavioral Disorders and Substances Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Akhondi A Hamadan Educational Organization, Ministry of Education, Hamadan, Iran.
  • Sadeghi Bahmani D Center for Affective, Stress, and Sleep Disorders, Psychiatric Clinics of the University of Basel, Basel, Switzerland.
  • Bajoghli H Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  • Holsboer-Trachsler E Center for Affective, Stress, and Sleep Disorders, Psychiatric Clinics of the University of Basel, Basel, Switzerland.
  • Brand S Center for Affective, Stress, and Sleep Disorders, Psychiatric Clinics of the University of Basel, Basel, Switzerland; Department of Sport, Exercise and Health Science, Sport Science Section, University of Basel, Basel, Switzerland.
Show more…
  • 2016-03-30
Published in:
  • Neuropsychiatric disease and treatment. - 2016
English BACKGROUND AND AIMS
The Montgomery-Asberg Depression Rating Scale (MADRS) is an expert's rating tool to assess the severity and symptoms of depression. The aim of the present two studies was to validate the Persian version of the MADRS and determine its test-retest reliability in patients diagnosed with major depressive disorders (MDD).


METHODS
In study 1, the translated MADRS and the Hamilton Depression Rating Scale (HDRS) were applied to 210 patients diagnosed with MDD and 100 healthy adults. In study 2, 200 patients diagnosed with MDD were assessed with the MADRS in face-to-face interviews. Thereafter, 100 patients were assessed 3-14 days later, again via face-to-face-interviews, while the other 100 patients were assessed 3-14 days later via a telephone interview.


RESULTS
Study 1: The MADRS and HDRS scores between patients with MDD and healthy controls differed significantly. Agreement between scoring of the MADRS and HDRS was high (r=0.95). Study 2: The intraclass correlation coefficient (test-retest reliability) was r=0.944 for the face-to-face interviews, and r=0.959 for the telephone interviews.


CONCLUSION
The present data suggest that the Persian MADRS has high validity and excellent test-retest reliability over a time interval of 3-14 days, irrespective of whether the second assessment was carried out face-to-face or via a telephone interview.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/98272
Statistics

Document views: 39 File downloads:
  • Full-text: 0